Article Information
- Received January 19, 2005
- Revision received April 25, 2005
- Accepted April 28, 2005
- First published June 1, 2005.
- Version of record published June 1, 2005.
Author Information
Author contributions
Disclosures
- Received January 19, 2005.
- Revision received April 25, 2005.
- Accepted April 28, 2005.
Most of this investigation was conducted in a facility constructed with support from Research Facilities Improvement Grant C06 RR-15518-01 from the National Center for Research Resources-National Institutes of Health (NIH). Work in the authors' laboratories was supported by NIH Grants GM54339 (M.W.Y.) and GM063911 (J.B.). We are very grateful to Jae Park, Paul Taghert, and the Bloomington Stock Center for providing antibodies and flies. Antibodies to ELAV, developed by Gerry Rubin, were obtained from the Developmental Studies Hybridoma Bank under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa (Iowa City, IA). We also thank Sue Chong and Meg Younger for excellent technical assistance and Ben Collins, Mark Drapeau, and Claude Desplan for invaluable comments on this manuscript.
Correspondence should be addressed to Justin Blau, Department of Biology, New York University, 100 Washington Square East, New York, NY 10003. E-mail: justin.blau{at}nyu.edu.
G. Yiannoulos' present address: Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468.
Copyright © 2005 Society for Neuroscience 0270-6474/05/255430-08$15.00/0
Online Impact